Skip to main content
SpringerLink
Log in

Screening for Fetal Abnormalities

  • Chapter
  • First Online:
Book cover Clinical Management of Pregnancies following ART

  • 586 Accesses

Abstract

In the UK, the National Institute of Clinical Excellence (NICE) recommends in its 2012 guideline on antenatal care that all pregnant women should be offered screening for fetal abnormalities as detailed by the UK National Screening Committee, (UK NSC) and its subgroup, the Fetal Anomaly Screening Programme (FASP). Worldwide, there is huge variation in the provision of antenatal screening for fetal anomalies, but where it is available, either privately or through the state, it tends to focus on the detection of aneuploidy (trisomies 13, 18 and 21) and structural abnormalities. This review summarises the already well established screening methods for fetal abnormalities and also introduces newer emerging techniques. Women conceiving by assisted reproductive technologies (ART) are faced by the same screening choices as those who conceive spontaneously, but the counselling they receive needs to take into account the method of conception and the impact that this has on the risk of anomalies, the performance of the screening tests and the attitudes of the women and their partners.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fetal Anomaly Screening Programme Standards 2015–2016. https://www.gov.uk/government/publications/fetal-anomaly-screening-programme-standards. First trimester combined screening for trisomy 13 and trisomy 18. External review against programme appraisal criteria for the UK National Screening Committee (UK NSC), version 5. Bazian Ltd. October 2013. http://legacy.screening.nhs.uk/t18andt13.

  2. Smith-Bindman R, Chu P, Goldberg JD. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Down syndrome. Prenat Diagn. 2007;27:535–44.

    Article  PubMed  Google Scholar 

  3. Cuckle H, Maymon R. Role of second-trimester ultrasound in screening for Down syndrome. Ultrasound Obstet Gynecol. 2013;41:241–4.

    Article  CAS  PubMed  Google Scholar 

  4. Cuckle H, Benn P, Pergament E. Cell-free DNA screening for fetal aneuploidy as a clinical service. Circulating nucleic acids, a Clinical Biochemistry Special Issue. 2015;48(15):932–41.

    Google Scholar 

  5. Agathokleous M, Chaveeva P, Poon LCY, Kosinski P, Nicolaides KH. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol. 2013;41:247–61.

    Article  CAS  PubMed  Google Scholar 

  6. Lo DYM, Corbetta N, Chamberlain P, Rai V, Sargent IL, Redman CWG, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–7.

    Article  CAS  PubMed  Google Scholar 

  7. Taylor Phillips S, Freeman K, Geppert J, Madan J, Uthman O, Agbebiyi A, Clarke A, Quenby S. Systematic review and cost consequences assessment of cell-free DNA testing for T21, T18 and T13 in the UK – Final Report. 2015. In press and available through the FASP website.

    Google Scholar 

  8. Benn P, Borrell A, Chiu R, Cuckle H, Dugoff L, Brigitte F, Gross S, Johnson J, Maymon R, Norton M, Odibo A, Schielen P, Spencer K, Huang T, Wright D, Yaron Y. Position Statement from the Chromosome Abnormality Screening Committee on Behalf of the Board of the International Society for Prenatal Diagnosis. 2014; https://www.ispdhome.org/docs/ISPD/Society%20Statements/PositionStatement_Current_8Apr2015.pdf.

  9. Chitty L, Cameron L, Daley R, Fisher J, Hill M, Jenkins L, Kroese M, McEwan A, McKay F, Morris S, Verhoef T, Wright D. RAPID non-invasive prenatal testing (NIPT) evaluation study: a report for the UK National Screening Committee (Executive Summary). 2015.

    Google Scholar 

  10. Jamar M, Lemarchal C, Lemaire V, Koulischer L, Bours V. A low rate of trisomy 21 in twin pregnancies: a cytogenetics retrospective study of 278 cases. Genet Couns. 2003;14:395–400.

    CAS  PubMed  Google Scholar 

  11. Boyle B, Morris J, McConkey R, Garne E, Loane M, Addor M, Gatt M, Haeusler M, Latos-Bielenska A, Lelong N, et al. Prevalence and risk of Down syndrome in monozygotic and dizygotic multiple pregnancies in Europe; implications for prenatal screening. BJOG. 2014;121:809–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Prats P, Rodriguez I, Comas C, Puerto B. First trimester risk assessment for trisomy 21 in twin pregnancies combining nuchal translucency and first trimester biochemical markers. Prenat Diagn. 2012;32:927–32.

    Article  PubMed  Google Scholar 

  13. Spencer K, Kagan K, Nicolaides K. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers. Prenat Diagn. 2008;28:49–52.

    Article  PubMed  Google Scholar 

  14. Prats P, Rodriguez I, Comas C, Puerto B. Systematic review of screening for T21 in twin pregnancies in 1st trimester combining NT and biochemical markers: a meta-analysis. Prenat Diagn. 2014;34:1077–83.

    Article  PubMed  Google Scholar 

  15. Spencer K, Staboulidou I, Nicolaides KH. First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers. Prenat Diagn. 2010;30:235–40.

    Article  CAS  PubMed  Google Scholar 

  16. Lewi L, Blickstein I, Van Schoubroeck D, Gloning KP, Casteels M, Brandenburg H, Fryns JP, Deprest J. Diagnosis and management of heterokaryotypic monochorionic twins. Am J Med Genet. 2006;140:272–5.

    Article  PubMed  Google Scholar 

  17. Agarwal K, Alfirevic Z. Pregnancy loss after chorionic villus sampling and genetic amniocentesis in twin pregnancies. a systematic review. Ultrasound Obstet Gynecol. 2012;40:128–34.

    Article  CAS  PubMed  Google Scholar 

  18. Monni G, Iuculano A, Zoppi M. Screening and invasive testing in twins. J Clin Med. 2014;3:865–82.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Gjerris AC, Loft A, Pinborg A, Christiansen M, Tabor A. Prenatal testing amongst women pregnant after assisted reproductive techniques in Denmark 1995-2000: a national cohort study. Hum Reprod. 2008;23:1545–52.

    Article  CAS  PubMed  Google Scholar 

  20. Abu-Musa AA, Nassar AH, Usta IM. Attitude of women with IVF and spontaneous pregnancies towards prenatal screening. Hum Reprod. 2008;23:2438–43.

    Article  PubMed  Google Scholar 

  21. Tul N, Novak-Antolic Z. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception. Prenat Diagn. 2006;26:1206–11.

    Article  CAS  PubMed  Google Scholar 

  22. Gjerris AC, Tabor A, Loft A, Christiansen M, Pinborg A. First trimester prenatal screening among women pregnant after IVF/ICSI. Hum Repro Update. 2012;18:350–9.

    Article  Google Scholar 

  23. Ewigman BG, Crane JP, Frigoletto FD, LeFevre ML, Bain RP, McNellis D. Effect of prenatal ultrasound screening on perinatal outcome. RADIUS Study Group. N Engl J Med. 1993;329:821–7.

    Article  CAS  PubMed  Google Scholar 

  24. Saari Kemppainen A, Karjalainen O, Ylostalo P, Heinonen OP. Ultrasound screening and perinatal mortality: controlled trial of systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial. Lancet. 1990;336:387–91.

    Article  CAS  PubMed  Google Scholar 

  25. Leivo T, Tuominen R, Saari-Kemppainen A, Ylostalo P, Karjalainen O, Heinonen OP. Cost-effectiveness of one-stage ultrasound screening in pregnancy: a report from the Helsinki ultrasound trial. Ultrasound Obstet Gynecol. 1996;7:309–14.

    Article  CAS  PubMed  Google Scholar 

  26. Roberts T, Henderson J, Mugford M, Bricker L, Neilson J, Garcia J. Antenatal ultrasound screening for fetal abnormalities: a systematic review of studies of cost and cost effectiveness. BJOG. 2002;109:44–56.

    Article  PubMed  Google Scholar 

  27. Betremieux P, Gaillot T, de la Pintiere A, Beuchee A, Pasquier L, Habonimana E, Le Bouar G, Branger B, Milon J, Fremond B, Wodey E, Odent S, Poulain P, Pladys P. Congenital diaphragmatic hernia: prenatal diagnosis permits immediate intensive care with high survival rate in isolated cases. A population-based study. Prenat Diagn. 2004;24:487–93.

    Article  PubMed  Google Scholar 

  28. Kirwan D. NHS Fetal Anomaly Screening programme. 18+0 to 20+6 weeks fetal anomaly scan. National Standards and Guidance for England. 2010. http://www.bmfms.org.uk/UserFiles/documents/nhs_fasp_fa_standards_and_gudance_2010.pdf.

  29. Salomon LJ, Alfirevic Z, Berghella C, Bilardo C, Hernandez-Andrade E, Johnsen SL, Kalache K, Leung KY, Malinger G, Munoz H, Prefumo F, Toi A. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2011;37(1):116–26.

    Article  CAS  PubMed  Google Scholar 

  30. Williams C, Sutcliffe A, Sebire NJ. Congenital malformations after assisted reproduction: risks and implications for prenatal diagnosis and fetal medicine. Ultrasound Obstet Gynecol. 2010;35:255–9.

    Article  CAS  PubMed  Google Scholar 

  31. Rimm AA, Katayama AC, Diaz M, Katayama KP. A meta-analysis of controlled studies comparing major malformation rates in IVF and ICSI infants with naturally conceived children. J Assist Reprod Genet. 2004;21:437–43.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Hansen M, Bower C, Milne E, de Klerk N, Kurinczuk JJ. Assisted reproductive technologies and the risk of birth defects – a systematic review. Hum Reprod. 2005;20:328–38.

    Article  PubMed  Google Scholar 

  33. Pandey S, Shetty A, Hamilton M, Bhattacharya S, Maheshwari A. Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis. Hum Repro Update. 2012;18:485–503.

    Article  Google Scholar 

  34. Sutcliffe AG, Peters CJ, Bowdin S, Temple K, Reardon W, Wilson L, Calyton-Smith J, Brueton LA, Bannister W, Maher ER. Assisted reproductive therapies and imprinting disorders – a preliminary British survey. Hum Reprod. 2006;21:1009–11.

    Article  CAS  PubMed  Google Scholar 

  35. Zhu JL, Basso O, Obel C, Bille C, Olsen J. Infertility, infertility treatment, and congenital malformations: Danish national birth cohort. BMJ. 2006;333:679–81.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology (Queens Medical Centre Campus), Nottingham University Hospitals NHS Trust, Nottingham, UK

    Alec McEwan BA, BM, BCh, MRCOG

Authors
  1. Alec McEwan BA, BM, BCh, MRCOG
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alec McEwan BA, BM, BCh, MRCOG .

Editor information

Editors and Affiliations

  1. Department of Maternity and Gynaecology, Royal Derby Hospital, University of Nottingham, Derby, United Kingdom

    Kanna Jayaprakasan

  2. Department of Obstetrics, Nottingham University Hospitals, Nottingham, United Kingdom

    Lucy Kean

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

McEwan, A. (2017). Screening for Fetal Abnormalities. In: Jayaprakasan, K., Kean, L. (eds) Clinical Management of Pregnancies following ART. Springer, Cham. https://doi.org/10.1007/978-3-319-42858-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42858-1_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42856-7

  • Online ISBN: 978-3-319-42858-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation